Aptevo Therapeutics Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Fuad El-Hibri. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Fuad El-Hibri har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:EBS / Emergent BioSolutions Inc. Director 206.434
US:APVO / Aptevo Therapeutics Inc. Director 7.373
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Fuad El-Hibri. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb APVO / Aptevo Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i APVO / Aptevo Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-07-29 APVO El-Hibri Fuad 55.015 0,8336 1.914 23,9660 45.861 10 13.7564 -19.544 -42,62
2019-07-23 APVO El-Hibri Fuad 10.000 0,8996 348 25,8635 8.996
2019-07-22 APVO El-Hibri Fuad 30.000 0,8867 1.043 25,4926 26.601
2019-07-19 APVO El-Hibri Fuad 26.460 0,8972 920 25,7945 23.740
2019-07-18 APVO El-Hibri Fuad 14.404 0,8745 501 25,1419 12.596
2019-07-17 APVO El-Hibri Fuad 19.136 0,8729 666 25,0959 16.704
2019-07-16 APVO El-Hibri Fuad 11.375 0,8494 396 24,4203 9.662
2019-07-11 APVO El-Hibri Fuad 14.691 0,8477 511 24,3714 12.454
2019-07-10 APVO El-Hibri Fuad 18.919 0,8488 658 24,4030 16.058

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APVO / Aptevo Therapeutics Inc. Insider Trades
Insidersalg APVO / Aptevo Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i APVO / Aptevo Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APVO / Aptevo Therapeutics Inc. Insider Trades
Insiderkøb EBS / Emergent BioSolutions Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i APVO / Aptevo Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EBS / Emergent BioSolutions Inc. Insider Trades
Insidersalg EBS / Emergent BioSolutions Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i APVO / Aptevo Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-02-06 EBS El-Hibri Fuad 11.684 61,9000 11.684 61,9000 723.240 43 49.34 -146.750 -20,29
2015-11-19 EBS El-Hibri Fuad 17.871 37,5000 17.871 37,5000 670.162
2015-11-13 EBS El-Hibri Fuad 13.013 36,5000 13.013 36,5000 474.974
2015-11-09 EBS El-Hibri Fuad 13.225 35,5000 13.225 35,5000 469.488
2015-11-06 EBS El-Hibri Fuad 13.450 34,5000 13.450 34,5000 464.025
2015-11-03 EBS El-Hibri Fuad 13.689 33,5000 13.689 33,5000 458.582
2013-04-18 EBS El-Hibri Fuad 62.851 15,0452 62.851 15,0452 945.606
2013-04-17 EBS El-Hibri Fuad 52.021 15,0196 52.021 15,0196 781.335
2012-12-04 EBS El-Hibri Fuad 43.064 15,0831 43.064 15,0831 649.539
2012-12-03 EBS El-Hibri Fuad 22.875 15,0197 22.875 15,0197 343.576
2012-11-30 EBS El-Hibri Fuad 34.061 15,2146 34.061 15,2146 518.224
2008-08-28 EBS El-Hibri Fuad 8.000 14,0000 8.000 14,0000 112.000
2008-08-28 EBS El-Hibri Fuad 200 14,0050 200 14,0050 2.801
2008-08-28 EBS El-Hibri Fuad 300 14,0100 300 14,0100 4.203
2008-08-28 EBS El-Hibri Fuad 500 14,0200 500 14,0200 7.010
2008-08-28 EBS El-Hibri Fuad 800 14,0300 800 14,0300 11.224
2008-08-28 EBS El-Hibri Fuad 100 14,0400 100 14,0400 1.404
2008-08-28 EBS El-Hibri Fuad 200 14,0500 200 14,0500 2.810
2008-08-28 EBS El-Hibri Fuad 3.700 14,0600 3.700 14,0600 52.022
2008-08-28 EBS El-Hibri Fuad 1.700 14,0700 1.700 14,0700 23.919
2008-08-28 EBS El-Hibri Fuad 400 14,0800 400 14,0800 5.632
2008-08-28 EBS El-Hibri Fuad 100 14,0850 100 14,0850 1.408
2008-08-28 EBS El-Hibri Fuad 350 14,0900 350 14,0900 4.932
2008-08-28 EBS El-Hibri Fuad 600 14,1000 600 14,1000 8.460
2008-08-28 EBS El-Hibri Fuad 300 14,1100 300 14,1100 4.233
2008-08-28 EBS El-Hibri Fuad 600 14,1200 600 14,1200 8.472
2008-08-28 EBS El-Hibri Fuad 700 14,1300 700 14,1300 9.891
2008-08-28 EBS El-Hibri Fuad 200 14,1400 200 14,1400 2.828
2008-08-28 EBS El-Hibri Fuad 100 14,1500 100 14,1500 1.415
2008-08-28 EBS El-Hibri Fuad 50 14,1600 50 14,1600 708
2008-08-28 EBS El-Hibri Fuad 800 14,1700 800 14,1700 11.336
2008-08-28 EBS El-Hibri Fuad 400 14,1800 400 14,1800 5.672
2008-08-28 EBS El-Hibri Fuad 1.000 14,1900 1.000 14,1900 14.190
2008-08-28 EBS El-Hibri Fuad 500 14,2000 500 14,2000 7.100
2008-08-28 EBS El-Hibri Fuad 200 14,2100 200 14,2100 2.842
2008-08-28 EBS El-Hibri Fuad 650 14,2200 650 14,2200 9.243
2008-08-28 EBS El-Hibri Fuad 100 14,2300 100 14,2300 1.423

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EBS / Emergent BioSolutions Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Fuad El-Hibri som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2021-12-07 2021-12-03 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 206.434 206.434
2021-12-07 2021-12-03 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 274.930 274.930
2021-12-07 2021-12-03 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 3.018.644 3.018.644
2021-12-07 2021-12-03 4 APVO Aptevo Therapeutics Inc.
Common Stock
J - Other 7.373 7.373
2021-12-07 2021-12-03 4 APVO Aptevo Therapeutics Inc.
Common Stock
J - Other 9.819 9.819
2021-12-07 2021-12-03 4 APVO Aptevo Therapeutics Inc.
Common Stock
J - Other 107.807 107.807
2021-06-02 2021-06-01 4 APVO Aptevo Therapeutics Inc.
Restricted Stock Unit
A - Award 893 893
2021-06-02 2021-06-01 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
A - Award 2.678 2.678
2021-02-26 2021-02-24 4 EBS Emergent BioSolutions Inc.
Restricted Stock Unit
A - Award 13.906 13.906
2021-02-26 2021-02-24 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
A - Award 27.808 27.808
2021-02-17 2020-07-02 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
A - Award 3.571 3.571
2020-11-12 2020-11-10 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
M - Exercise X -19.391 0 -100,00
2020-11-12 2020-11-10 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -19.391 1.123.988 -1,70 88,21 -1.710.480 99.146.981
2020-11-12 2020-11-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 19.391 1.143.379 1,73 26,45 512.892 30.242.375
2020-11-12 2020-11-09 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
M - Exercise X -20.000 19.391 -50,77
2020-11-12 2020-11-09 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.123.988 -1,75 95,26 -1.905.200 107.071.097
2020-11-12 2020-11-09 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.143.988 1,78 26,45 529.000 30.258.483
2020-11-04 2020-11-03 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
M - Exercise X -20.000 39.391 -33,68
2020-11-04 2020-11-03 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.123.988 -1,75 90,74 -1.814.800 101.990.671
2020-11-04 2020-11-03 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.143.988 1,78 26,45 529.000 30.258.483
2020-11-04 2020-11-02 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
M - Exercise X -20.000 59.391 -25,19
2020-11-04 2020-11-02 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.123.988 -1,75 90,44 -1.808.800 101.653.475
2020-11-04 2020-11-02 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.143.988 1,78 26,45 529.000 30.258.483
2020-09-25 2020-09-24 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -12.535 1.123.988 -1,10 98,85 -1.239.085 111.106.214
2020-09-25 2020-09-23 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -13.000 1.136.523 -1,13 100,58 -1.307.540 114.311.483
2020-09-18 2020-09-17 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.149.523 -1,71 100,68 -2.013.600 115.733.976
2020-09-18 2020-09-16 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.169.523 -1,68 102,48 -2.049.600 119.852.717
2020-09-11 2020-09-10 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.189.523 -1,65 102,66 -2.053.200 122.116.431
2020-09-11 2020-09-09 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.209.523 -1,63 102,80 -2.056.000 124.338.964
2020-07-29 2020-07-27 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
A - Award 170 170
2020-07-29 2020-07-27 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
A - Award 1.322 1.322
2020-07-29 2020-07-27 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
D - Sale to Issuer -1.785 0 -100,00
2020-07-29 2020-07-27 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
D - Sale to Issuer -892 0 -100,00
2020-07-29 2020-07-27 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
D - Sale to Issuer -1.339 0 -100,00
2020-05-01 2020-04-30 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.229.523 -1,60 74,01 -1.480.200 90.996.997
2020-05-01 2020-04-29 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.249.523 -1,58 74,24 -1.484.800 92.764.588
2020-04-24 2020-04-23 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.269.523 -1,55 68,49 -1.369.800 86.949.630
2020-04-24 2020-04-22 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.289.523 -1,53 66,81 -1.336.200 86.153.032
2020-04-20 2020-04-16 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.309.523 -1,50 62,47 -1.249.400 81.805.902
2020-04-15 2020-04-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -12.537 1.329.523 -0,93 62,58 -784.565 83.201.549
2020-04-15 2020-04-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.261 1.342.060 -0,46 62,99 -394.380 84.536.359
2020-04-15 2020-04-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -17.071 1.348.321 -1,25 62,25 -1.062.670 83.932.982
2020-04-10 2020-04-09 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -23.716 1.365.392 -1,71 61,83 -1.466.360 84.422.187
2020-04-10 2020-04-08 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -24.362 1.389.108 -1,72 61,34 -1.494.365 85.207.885
2020-04-10 2020-04-08 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -13.000 1.413.470 -0,91 60,75 -789.750 85.868.302
2020-04-08 2020-04-07 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -14.336 1.426.470 -0,99 60,76 -871.055 86.672.317
2020-04-08 2020-04-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -28.240 1.440.806 -1,92 60,50 -1.708.520 87.168.763
2020-02-28 2020-02-27 4 EBS Emergent BioSolutions Inc.
Restricted Stock Unit
M - Exercise -9.794 37.980 -20,50
2020-02-28 2020-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -9.837 1.469.046 -0,67 56,97 -560.414 83.691.551
2020-02-28 2020-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.854 1.478.883 -0,26 58,42 -225.151 86.396.345
2020-02-28 2020-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.794 1.482.737 0,66
2020-02-28 2020-02-26 4 EBS Emergent BioSolutions Inc.
Restricted Stock Unit
M - Exercise -6.429 47.774 -11,86
2020-02-28 2020-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -13.619 1.472.943 -0,92 58,70 -799.435 86.461.754
2020-02-28 2020-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.530 1.486.562 -0,17 59,91 -151.572 89.059.929
2020-02-28 2020-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 6.429 1.489.092 0,43
2020-02-28 2020-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.365 1.482.663 -0,16 59,91 -141.687 88.826.340
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Restricted Stock Unit
M - Exercise -6.010 54.203 -9,98
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Restricted Stock Unit
A - Award 19.532 60.213 48,01
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
A - Award 39.061 39.061
2020-02-27 2020-02-25 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 6.010 1.485.028 0,41
2020-02-24 2020-02-21 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -18.567 0 -100,00
2020-02-24 2020-02-21 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -18.567 1.479.018 -1,24 64,90 -1.204.998 95.988.268
2020-02-24 2020-02-21 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 18.567 1.497.585 1,26 25,62 475.687 38.368.128
2020-02-24 2020-02-20 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -4.751 18.567 -20,37
2020-02-24 2020-02-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -4.751 1.479.018 -0,32 64,90 -308.340 95.988.268
2020-02-24 2020-02-20 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 4.751 1.483.769 0,32 25,62 121.721 38.014.162
2020-02-19 2020-02-18 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -15.614 23.318 -40,11
2020-02-19 2020-02-18 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -15.614 1.479.018 -1,04 63,90 -997.735 94.509.250
2020-02-19 2020-02-18 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 15.614 1.494.632 1,06 25,62 400.031 38.292.472
2020-02-19 2020-02-14 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -4.386 38.932 -10,13
2020-02-19 2020-02-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -4.386 1.479.018 -0,30 63,90 -280.265 94.509.250
2020-02-19 2020-02-14 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 4.386 1.483.404 0,30 25,62 112.369 38.004.810
2020-02-13 2020-02-12 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -13.720 43.318 -24,05
2020-02-13 2020-02-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -13.720 1.479.018 -0,92 62,90 -862.988 93.030.232
2020-02-13 2020-02-12 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 13.720 1.492.738 0,93 25,62 351.506 38.243.948
2020-02-13 2020-02-11 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -6.280 57.038 -9,92
2020-02-13 2020-02-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.280 1.479.018 -0,42 62,90 -395.012 93.030.232
2020-02-13 2020-02-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 6.280 1.485.298 0,42 25,62 160.894 38.053.335
2020-02-13 2020-02-06 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -11.684 63.318 -15,58
2020-02-13 2020-02-06 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 11.684 1.479.018 0,80 25,62 299.344 37.892.441
2020-02-13 2020-02-05 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -8.316 75.002 -9,98
2020-02-13 2020-02-05 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -20.000 83.318 -19,36
2020-02-13 2020-02-05 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -20.000 103.318 -16,22
2020-02-13 2020-02-05 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 8.316 1.479.018 0,57 25,62 213.056 37.892.441
2020-02-13 2020-02-05 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.519.018 1,33 25,62 512.400 38.917.241
2020-02-13 2020-02-05 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.499.018 1,35 25,62 512.400 38.404.841
2020-02-07 2020-02-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -11.684 1.419.018 -0,82 61,90 -723.240 87.837.214
2020-02-07 2020-02-05 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -48.316 1.430.702 -3,27 60,66 -2.930.849 86.786.383
2019-08-13 2019-08-12 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase X 100.000 1.124.536 9,76 0,76 75.520 849.250
2019-07-30 2019-07-29 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 55.015 1.024.536 5,67 0,83 45.861 854.053
2019-07-24 2019-07-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 10.000 969.521 1,04 0,90 8.996 872.181
2019-07-23 2019-07-22 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 30.000 959.521 3,23 0,89 26.601 850.807
2019-07-19 2019-07-19 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 26.460 929.521 2,93 0,90 23.740 833.966
2019-07-18 2019-07-17 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 19.136 888.657 2,20 0,87 16.704 775.709
2019-07-18 2019-07-18 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 14.404 903.061 1,62 0,87 12.596 789.727
2019-07-16 2019-07-16 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 11.375 869.521 1,33 0,85 9.662 738.571
2019-07-12 2019-07-11 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 14.691 858.146 1,74 0,85 12.454 727.450
2019-07-11 2019-07-10 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 18.919 843.455 2,29 0,85 16.058 715.925
2019-06-04 2019-06-01 4 APVO Aptevo Therapeutics Inc.
Option (right to buy)
A - Award 25.000 25.000
2019-02-28 2019-02-28 4 EBS Emergent BioSolutions Inc.
Restricted Stock Units
M - Exercise -9.722 40.681 -19,29
2019-02-28 2019-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.826 1.479.018 -0,26 58,71 -224.624 86.833.147
2019-02-28 2019-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.722 1.482.844 0,66
2019-02-28 2019-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.987 1.473.122 -0,47 58,47 -408.530 86.133.443
2019-02-28 2019-02-27 4 EBS Emergent BioSolutions Inc.
Restricted Stock Units
M - Exercise -9.794 50.403 -16,27
2019-02-28 2019-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.486 1.480.109 -0,17 57,98 -144.138 85.816.720
2019-02-28 2019-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.794 1.482.595 0,66
2019-02-28 2019-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -10.369 1.472.801 -0,70 58,24 -603.891 85.775.930
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Stock Options (Right to Buy)
A - Award 36.053 36.053
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Restricted Stock Units
A - Award 18.029 60.197 42,76
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Restricted Stock Units
M - Exercise -6.430 42.168 -13,23
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.566 1.483.170 -0,11 61,01 -95.542 90.488.202
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 6.430 1.484.736 0,43
2019-02-28 2019-02-26 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -10.369 1.478.306 -0,70 59,65 -618.511 88.180.953
2019-02-20 2018-11-27 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -20.832 0 -100,00
2019-02-20 2018-11-27 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.832 1.488.675 -1,38 69,59 -1.449.699 103.596.893
2019-02-20 2018-11-27 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.832 1.509.507 1,40 13,38 278.732 20.197.204
2019-02-20 2018-11-26 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -25.000 20.832 -54,55
2019-02-20 2018-11-26 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 25.000 1.513.675 1,68 13,38 334.500 20.252.972
2019-02-20 2018-11-20 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -15.173 0 -100,00
2019-02-20 2018-11-20 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 15.173 1.503.848 1,02 14,44 219.098 21.715.565
2019-02-20 2018-11-19 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise X -20.000 15.173 -56,86
2019-02-20 2018-11-19 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.508.675 1,34 14,44 288.800 21.785.267
2018-11-28 2018-11-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.832 1.407.670 -1,46 69,59 -1.449.699 97.959.755
2018-11-28 2018-11-26 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.428.502 -1,72 69,96 -1.749.000 99.938.000
2018-11-21 2018-11-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -15.173 1.453.502 -1,03 70,03 -1.062.565 101.788.745
2018-11-21 2018-11-19 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.468.675 -1,34 69,54 -1.390.800 102.131.660
2018-08-15 2018-08-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -16.318 1.488.675 -1,08 56,57 -923.109 84.214.345
2018-08-15 2018-08-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.504.993 -1,31 55,50 -1.110.000 83.527.112
2018-07-16 2018-07-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.600 1.524.993 -0,17 54,52 -141.752 83.142.618
2018-07-16 2018-07-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -12.400 1.527.593 -0,81 54,50 -675.800 83.253.818
2018-07-11 2018-07-09 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -15.000 1.539.993 -0,96 53,61 -804.150 82.559.025
2018-06-04 2018-06-01 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
A - Award 25.000 25.000
2018-03-13 2018-03-09 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -13.237 48.598 -21,41
2018-03-13 2018-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.224 1.554.993 -0,21 51,84 -167.132 80.610.837
2018-03-13 2018-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 13.237 1.558.217 0,86
2018-03-01 2018-02-28 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -9.723 61.835 -13,59
2018-03-01 2018-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.368 1.544.980 -0,15 49,97 -118.329 77.202.651
2018-03-01 2018-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.723 1.547.348 0,63
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -9.794 71.558 -12,04
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
A - Award 38.577 38.577
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
A - Award 19.288 81.352 31,08
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.385 1.537.625 -0,15 49,64 -118.391 76.327.705
2018-03-01 2018-02-27 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.794 1.540.010 0,64
2017-11-30 2017-11-29 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -27.983 0 -100,00
2017-11-30 2017-11-29 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -27.983 1.530.216 -1,80 42,08 -1.177.525 64.391.489
2017-11-30 2017-11-29 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 27.983 1.558.199 1,83 22,03 616.465 34.327.124
2017-11-30 2017-11-28 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -20.000 27.983 -41,68
2017-11-30 2017-11-28 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.530.216 -1,29 41,59 -831.800 63.641.683
2017-11-30 2017-11-28 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.550.216 1,31 22,03 440.600 34.151.258
2017-11-17 2017-11-14 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -20.000 47.983 -29,42
2017-11-17 2017-11-14 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.530.216 -1,29 40,05 -801.000 61.285.151
2017-11-17 2017-11-14 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.550.216 1,31 22,03 440.600 34.151.258
2017-11-17 2017-11-13 4/A EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -20.000 67.983 -22,73
2017-11-17 2017-11-13 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.530.216 -1,29 40,69 -813.800 62.264.489
2017-11-17 2017-11-13 4/A EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.550.216 1,31 22,03 440.600 34.151.258
2017-11-15 2017-11-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.490.216 -1,32 40,05 -801.000 59.683.151
2017-11-15 2017-11-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.510.216 -1,31 40,69 -813.800 61.450.689
2017-09-29 2017-09-29 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.530.216 -1,61 40,50 -1.012.500 61.973.748
2017-09-29 2017-09-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.555.216 -1,58 39,50 -987.500 61.431.032
2017-09-14 2017-09-14 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -23.547 1.580.216 -1,47 38,50 -906.560 60.838.316
2017-09-14 2017-09-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -1.453 1.603.763 -0,09 38,50 -55.940 61.744.876
2017-09-08 2017-09-07 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -16.439 1.605.216 -1,01 37,50 -616.462 60.195.600
2017-09-06 2017-09-05 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -3.100 1.621.655 -0,19 37,50 -116.250 60.812.062
2017-09-01 2017-08-31 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -5.461 1.624.755 -0,33 37,50 -204.788 60.928.312
2017-07-28 2017-07-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.630.216 -1,51 36,50 -912.500 59.502.884
2017-07-21 2017-07-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.655.216 -1,49 35,50 -887.500 58.760.168
2017-06-01 2017-06-01 4 APVO Aptevo Therapeutics Inc.
Employee Stock Option (right to buy)
A - Award 12.500 12.500
2017-03-10 2017-03-10 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -20.554 62.064 -24,88
2017-03-10 2017-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -6.089 1.680.216 -0,36 31,05 -189.063 52.170.707
2017-03-10 2017-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 20.554 1.686.305 1,23
2017-03-10 2017-03-09 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -13.236 82.618 -13,81
2017-03-10 2017-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.621 1.665.751 -0,22 30,98 -112.179 51.604.966
2017-03-10 2017-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 13.236 1.669.372 0,80
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 58.747 58.747
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -9.722 95.854 -9,21
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
A - Award 29.382 105.576 38,56
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2.659 1.656.136 -0,16 30,63 -81.445 50.727.446
2017-03-02 2017-02-28 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9.722 1.658.795 0,59
2016-08-05 2016-08-03 4 APVO Aptevo Therapeutics Inc.
Stock Option (right to buy)
A - Award 18.750 18.750
2016-05-27 2016-05-27 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -9.835 1.649.073 -0,59 43,50 -427.822 71.734.676
2016-05-26 2016-05-26 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise X -24.594 0 -100,00
2016-05-26 2016-05-26 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -15.165 1.658.908 -0,91 43,50 -659.678 72.162.498
2016-05-26 2016-05-26 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -24.594 1.674.073 -1,45 42,90 -1.055.083 71.817.732
2016-05-26 2016-05-26 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 24.594 1.698.667 1,47 15,91 391.291 27.025.792
2016-05-25 2016-05-25 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise X -20.000 24.594 -44,85
2016-05-25 2016-05-25 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.674.073 -1,18 42,57 -851.400 71.265.288
2016-05-25 2016-05-25 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.694.073 1,19 15,91 318.200 26.952.701
2016-05-25 2016-05-24 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise X -20.000 44.594 -30,96
2016-05-25 2016-05-24 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.674.073 -1,18 42,26 -845.200 70.746.325
2016-05-25 2016-05-24 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.694.073 1,19 15,91 318.200 26.952.701
2016-05-25 2016-05-23 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise X -20.000 64.594 -23,64
2016-05-25 2016-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.674.073 -1,47 42,50 -1.062.500 71.148.102
2016-05-25 2016-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.000 1.699.073 -1,16 42,76 -855.200 72.652.361
2016-05-25 2016-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.719.073 1,18 15,91 318.200 27.350.451
2016-05-13 2016-05-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.699.073 -1,45 38,71 -967.750 65.771.116
2016-04-25 2016-04-22 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -4.209 1.724.073 -0,24 40,50 -170.464 69.824.956
2016-04-20 2016-04-18 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -20.791 1.728.282 -1,19 40,50 -842.036 69.995.421
2016-04-08 2016-04-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.749.073 -1,41 39,50 -987.500 69.088.384
2016-04-08 2016-04-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -25.000 1.774.073 -1,39 38,50 -962.500 68.301.810
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -6.967 69.196 -9,15
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.902 1.799.073 -0,11 34,22 -65.086 61.564.278
2016-03-15 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 6.967 1.800.975 0,39
2016-03-11 2016-03-10 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -18.746 76.163 -19,75
2016-03-11 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -5.128 1.794.008 -0,29 34,38 -176.301 61.677.995
2016-03-11 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 18.746 1.799.136 1,05
2016-03-11 2016-03-09 4 EBS Emergent BioSolutions Inc.
Restrictive Stock Units
M - Exercise -12.073 94.909 -11,29
2016-03-11 2016-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.288 1.780.390 -0,18 34,60 -113.765 61.601.494
2016-03-11 2016-03-09 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 12.073 1.783.678 0,68
2016-03-11 2016-03-01 4/A EBS Emergent BioSolutions Inc.
Restrictive Stock Units
A - Award 26.303 106.982 32,60
2016-03-03 2016-03-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 53.192 53.192
2016-03-03 2016-03-01 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 26.303 1.797.908 1,48
2015-11-19 2015-11-19 4 EBS Emergent BioSolutions Inc.
Employee Stock Option
M - Exercise -27.900 0 -100,00
2015-11-19 2015-11-19 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -17.871 1.852.284 -0,96 37,50 -670.162 69.460.650
2015-11-19 2015-11-19 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 27.900 1.870.155 1,51 18,90 527.310 35.345.930
2015-11-16 2015-11-13 4 EBS Emergent BioSolutions Inc.
Employee Stock Option
M - Exercise -20.000 27.900 -41,75
2015-11-16 2015-11-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -13.013 1.842.255 -0,70 36,50 -474.974 67.242.308
2015-11-16 2015-11-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.855.268 1,09 18,90 378.000 35.064.565
2015-11-10 2015-11-09 4 EBS Emergent BioSolutions Inc.
Employee Stock Option
M - Exercise -20.000 47.900 -29,46
2015-11-10 2015-11-09 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -13.225 1.835.268 -0,72 35,50 -469.488 65.152.014
2015-11-10 2015-11-09 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.848.493 1,09 18,90 378.000 34.936.518
2015-11-06 2015-11-06 4 EBS Emergent BioSolutions Inc.
Employee Stock Option
M - Exercise -20.000 67.900 -22,75
2015-11-06 2015-11-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -13.450 1.828.493 -0,73 34,50 -464.025 63.083.008
2015-11-06 2015-11-06 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.841.943 1,10 18,90 378.000 34.812.723
2015-11-04 2015-11-03 4 EBS Emergent BioSolutions Inc.
Employee Stock Option
M - Exercise -20.000 87.900 -18,54
2015-11-04 2015-11-03 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -13.689 1.821.943 -0,75 33,50 -458.582 61.035.090
2015-11-04 2015-11-03 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 20.000 1.835.632 1,10 18,90 378.000 34.693.445
2015-08-10 2015-08-10 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -30.000 1.815.632 -1,63 35,50 -1.065.000 64.454.936
2015-08-07 2015-08-06 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -29.766 1.845.632 -1,59 34,50 -1.026.927 63.674.304
2015-07-22 2015-07-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -234 1.875.398 -0,01 34,50 -8.073 64.701.231
2015-06-22 2015-06-22 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -30.000 1.875.632 -1,57 33,00 -990.000 61.895.856
2015-06-22 2015-06-19 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -30.000 1.905.632 -1,55 32,50 -975.000 61.933.040
2015-06-22 2015-06-18 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -14.564 1.935.632 -0,75 32,00 -466.048 61.940.224
2015-06-15 2015-06-15 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -368 1.950.196 -0,02 32,00 -11.776 62.406.272
2015-06-15 2015-06-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -15.068 1.950.564 -0,77 32,03 -482.630 62.476.760
2015-06-15 2015-06-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -30.000 1.965.632 -1,50 32,26 -967.923 63.419.347
2015-03-13 2015-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.463 1.995.632 -0,07 28,67 -41.944 57.214.769
2015-03-13 2015-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.906 1.997.095 -0,10 28,99 -55.255 57.895.784
2015-03-13 2015-03-10 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
A - Award 72.413 72.413
2015-03-13 2015-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -5.128 1.999.001 -0,26 29,00 -148.712 57.971.029
2015-03-13 2015-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 36.219 2.004.129 1,84
2015-01-21 2015-01-20 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (right to buy)
M - Exercise X -33.333 0 -100,00
2015-01-21 2015-01-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -7.303 1.967.910 -0,37 28,24 -206.232 55.572.401
2015-01-21 2015-01-20 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -8.022 1.975.213 -0,40 27,16 -217.853 53.640.859
2015-01-21 2015-01-20 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise X 33.333 1.983.235 1,71 7,00 233.331 13.882.645
2014-12-11 2014-12-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -68.413 1.949.902 -3,39 26,00 -1.778.738 50.697.452
2014-12-11 2014-12-10 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -416 2.018.315 -0,02 26,00 -10.816 52.476.190
2014-12-11 2014-12-09 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -50.512 2.018.731 -2,44 26,00 -1.313.312 52.487.006
2014-12-01 2014-11-28 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -13.597 0 -100,00 25,00 -339.925
2014-12-01 2014-11-28 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -5.135 0 -100,00 25,00 -128.375
2014-12-01 2014-11-28 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -14.355 0 -100,00 25,00 -358.875
2014-12-01 2014-11-26 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -1.490 14.355 -9,40 25,00 -37.250 358.875
2014-11-26 2014-11-25 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.126 5.135 -29,28 25,00 -53.150 128.375
2014-11-26 2014-11-24 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -500 13.597 -3,55 25,00 -12.500 339.925
2014-11-26 2014-11-24 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -6.388 7.261 -46,80 25,00 -159.700 181.525
2014-11-14 2014-11-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -115 14.097 -0,81 25,00 -2.875 352.425
2014-11-14 2014-11-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -2.196 13.649 -13,86 25,00 -54.900 341.225
2014-11-10 2014-08-26 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -70.796 2.069.243 -3,31 25,00 -1.769.900 51.731.075
2014-11-10 2014-09-02 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale X -1.633 14.212 -10,31 25,00 -40.825 355.300
2014-09-03 2014-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes X -1.633 14.212 -10,31 25,00 -40.825 355.300
2014-08-27 2014-08-26 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes X -70.769 2.069.243 -3,31 25,00 -1.769.225 51.731.075
2014-04-08 2014-03-14 4/A EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.659 2.140.039 -0,17 27,06 -99.013 57.909.455
2014-03-14 2014-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.659 2.141.275 -0,17 27,06 -99.013 57.942.902
2014-03-14 2014-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.463 2.144.934 -0,07 27,15 -39.720 58.234.958
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
A - Award 112.479 112.479
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.887 2.144.510 -0,09 28,09 -53.006 60.239.286
2014-03-12 2014-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 56.240 2.146.397 2,69
2013-06-04 2013-05-31 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 347.488 2.090.157 19,94
2013-04-19 2013-04-18 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -62.851 1.742.669 -3,48 15,05 -945.606 26.218.804
2013-04-19 2013-04-17 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -52.021 1.805.520 -2,80 15,02 -781.335 27.118.188
2013-04-19 2013-03-12 4/A EBS Emergent BioSolutions Inc.
Common Stock
A - Award 20.902 1.861.191 1,14
2013-04-19 2013-03-12 4/A EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.463 1.840.289 -0,08 14,67 -21.462 26.997.040
2013-04-19 2013-03-08 4/A EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.818 1.841.752 -0,21 15,22 -58.110 28.031.465
2013-04-18 2013-03-14 4/A EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.659 1.857.532 -0,20 14,46 -52.909 26.859.913
2013-03-18 2013-03-08 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -4.294 1.856.053 -0,23 14,46 -62.091 26.838.526
2013-03-12 2013-03-12 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy)
A - Award 41.804 41.804
2013-03-12 2013-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 20.902 1.860.347 1,14
2013-03-12 2013-03-12 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -1.717 1.839.445 -0,09 14,67 -25.188 26.984.658
2013-03-12 2013-03-08 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -4.408 1.841.162 -0,24 15,22 -67.090 28.022.486
2012-12-14 2012-12-14 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift 149.712 149.712
2012-12-14 2012-12-14 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift 13.333 13.333
2012-12-14 2012-12-14 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift 13.333 13.333
2012-12-14 2012-12-14 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift -176.378 127.721 -58,00
2012-12-14 2012-12-14 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift 224.628 224.628
2012-12-14 2012-12-12 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift 304.098 304.098
2012-12-06 2012-12-04 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -43.064 1.845.570 -2,28 15,08 -649.539 27.836.917
2012-12-03 2012-12-03 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -22.875 1.888.634 -1,20 15,02 -343.576 28.366.716
2012-12-03 2012-11-30 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -34.061 1.911.509 -1,75 15,21 -518.224 29.082.845
2012-09-20 2012-09-18 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 150.000 1.945.570 8,35
2012-09-20 2012-09-18 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -150.000 4.344.250 -3,34
2012-06-06 2012-06-04 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -33.702 4.494.250 -0,74
2012-05-17 2012-05-16 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -191.950 4.527.952 -4,07
2012-05-17 2012-05-16 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 281.190 1.795.570 18,57
2012-05-09 2012-05-08 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -779.951 4.719.902 -14,18
2012-05-09 2012-05-08 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -45.647 5.499.853 -0,82
2012-05-09 2012-05-08 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -45.647 5.499.853 -0,82
2012-05-09 2012-05-08 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other -45.647 5.591.147 -0,81
2012-03-16 2012-03-14 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.538 1.514.380 -0,23 16,05 -56.785 24.305.799
2012-03-16 2012-03-13 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy)
A - Award 32.100 32.100
2012-03-16 2012-03-13 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 16.050 1.517.918 1,07
2012-03-12 2012-03-08 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3.730 1.501.868 -0,25 14,49 -54.048 21.762.067
2008-10-01 2008-09-29 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -1.700 7.777.935 -0,02 15,17 -25.789 117.991.274
2008-10-01 2008-09-29 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -2.200 7.779.635 -0,03 15,00 -33.000 116.694.525
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -100 7.829.185 0,00 14,23 -1.423 111.409.303
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -650 7.829.285 -0,01 14,22 -9.243 111.332.433
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -200 7.829.935 0,00 14,21 -2.842 111.263.376
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -500 7.830.135 -0,01 14,20 -7.100 111.187.917
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -1.000 7.830.635 -0,01 14,19 -14.190 111.116.711
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -400 7.831.635 -0,01 14,18 -5.672 111.052.584
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -800 7.832.035 -0,01 14,17 -11.336 110.979.936
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -50 7.832.835 0,00 14,16 -708 110.912.944
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -100 7.832.885 0,00 14,15 -1.415 110.835.323
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -200 7.832.985 0,00 14,14 -2.828 110.758.408
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -700 7.833.185 -0,01 14,13 -9.891 110.682.904
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -600 7.833.885 -0,01 14,12 -8.472 110.614.456
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -300 7.834.485 0,00 14,11 -4.233 110.544.583
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -600 7.834.785 -0,01 14,10 -8.460 110.470.468
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -350 7.835.385 0,00 14,09 -4.932 110.400.575
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -100 7.835.735 0,00 14,08 -1.408 110.366.327
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -400 7.835.835 -0,01 14,08 -5.632 110.328.557
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -1.700 7.836.235 -0,02 14,07 -23.919 110.255.826
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -3.700 7.837.935 -0,05 14,06 -52.022 110.201.366
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -200 7.841.635 0,00 14,05 -2.810 110.174.972
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -100 7.841.835 0,00 14,04 -1.404 110.099.363
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -800 7.841.935 -0,01 14,03 -11.224 110.022.348
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -500 7.842.735 -0,01 14,02 -7.010 109.955.145
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -300 7.843.235 0,00 14,01 -4.203 109.883.722
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -200 7.843.535 0,00 14,00 -2.801 109.848.708
2008-09-05 2008-08-28 4/A EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -8.000 7.843.735 -0,10 14,00 -112.000 109.812.290
2006-11-14 3 EBS Emergent BioSolutions Inc.
Common Stock
8.314.819
2006-11-14 3 EBS Emergent BioSolutions Inc.
Common Stock
4.065.043
2006-11-14 3 EBS Emergent BioSolutions Inc.
Common Stock
1.599.155
2006-11-14 3 EBS Emergent BioSolutions Inc.
Common Stock
719.275
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)